Detalles de la búsqueda
1.
The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review.
Oncologist;
29(5): e580-e600, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38309719
2.
The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysis.
Breast Cancer Res Treat;
204(3): 443-452, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240935
3.
Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer.
Future Oncol;
20(4): 207-214, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38328890
4.
Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy.
Int J Clin Oncol;
2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38565751
5.
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study.
Int J Clin Oncol;
29(3): 258-265, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310597
6.
Sirolimus experience in adult patients with vascular malformations.
Vascular;
: 17085381241241853, 2024 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38523367
7.
Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy.
Int J Cancer;
152(4): 679-685, 2023 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36082448
8.
Comparison of PD-L1 and VISTA expression status in primary and recurrent/refractory tissue after (chemo)radiotherapy in head and neck cancer.
Strahlenther Onkol;
199(8): 761-772, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36862156
9.
A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer.
Anticancer Drugs;
34(10): 1190-1192, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36729128
10.
The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors.
Anticancer Drugs;
34(6): 783-790, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36729111
11.
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Future Oncol;
19(10): 727-736, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37133230
12.
Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data.
Support Care Cancer;
31(12): 624, 2023 Oct 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37819422
13.
Role of sarcopenia on survival and treatment-related toxicity in head and neck cancer: a narrative review of current evidence and future perspectives.
Eur Arch Otorhinolaryngol;
280(8): 3541-3556, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37188907
14.
The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma.
Eur Arch Otorhinolaryngol;
280(5): 2471-2478, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36565325
15.
Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment.
Anticancer Drugs;
33(1): e477-e485, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34261917
16.
The benefit of immunotherapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Future Oncol;
2022 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36533987
17.
Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience.
Future Oncol;
18(3): 323-331, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34758639
18.
Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis.
Support Care Cancer;
30(11): 9071-9078, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35972646
19.
HER2-low breast cancer could be associated with an increased risk of brain metastasis.
Int J Clin Oncol;
27(2): 332-339, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34661778
20.
The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study.
Turk J Med Sci;
52(5): 1551-1558, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36422490